Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
Scott B. Ficarro(Harvard University), Forest M. White(Center for Cancer Research), Jeffrey Shabanowitz(University of Virginia), Mark L. McCleland(Revolution Medicines (United States)), Daniel J. Burke(University of Virginia), P. Todd Stukenberg(University of Virginia), Mark M. Ross, Donald F. Hunt(University of Virginia)
Cited by 1,631
Related Papers
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
|The Lancet|2021|1.5k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
|Journal of Clinical Oncology|2021|818
Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules
|Molecular & Cellular Proteomics|2005|547